AI Article Synopsis
- The text discusses the case of a 31-year-old pregnant woman who has chronic hepatitis B and contracted COVID-19 during her pregnancy, which is a significant health concern.
- She was hospitalized at 29 weeks of gestation after stopping her antiviral treatment for hepatitis B and tested positive for SARS-CoV-2.
- The treatment involved using liver protective and antiviral medications along with low-dose dexamethasone, which successfully managed her critical condition.
Article Abstract
Currently, infection with coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), during pregnancy is a problem worthy of attention, especially in patients with underlying diseases. In this case report, we present a case of chronic active hepatitis B with COVID-19 in pregnancy. A 31-year-old woman at 29 weeks of gestation who had a history of chronic hepatitis B virus infection discontinued antiviral treatment, was admitted to the hospital with chronic active hepatitis B, and tested positive for SARS-CoV-2 infection. In this case, we applied liver protective and antiviral agents, and low-dose dexamethasone therapy to successfully treat the critically ill pregnant woman suffering from chronic active hepatitis B combined with COVID-19.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868702 | PMC |
| http://dx.doi.org/10.14218/JCTH.2020.00085 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!